- Robot
- open access
- GSL/OTC & Rx
- Prescription Required
For information purpose only - these preparations are not or are not yet available
(†) indicates a preparation that is either no longer authorized, manufactured or marketed.
(*) indicates a preparation that was recently authorized
(») indicates a preparation that is temporarily suspended
(†) indicates a preparation that is either no longer authorized, manufactured or marketed.
(*) indicates a preparation that was recently authorized
(») indicates a preparation that is temporarily suspended
1.
Roemmers (Argentina)
Ezetimibe
hypercholesterolaemia
2.
Pierre fabre (France, Israel, Austria, Portugal, Finland, Argentina, Czech Republic, Russia, Turkey, Poland)
Milnacipran hydrochloride
depression
3.
Roche (Brazil)
Milnacipran hydrochloride
depression
4.
Silesia (Chile)
Milnacipran hydrochloride
depression
5.
Bms (United States)
Ixabepilone
breast cancer
6. (†)
Cimex (Switzerland)
Cinnarizine
peripheral and cerebral vascular disorders
7.
Menarini (Spain)
Olmesartan medoxomil
hypertension
8.
Best (Mexico)
dl-Alpha tocoferil acetate
antoxidant
9.
Phoinix pharm (Greece)
Budesonide
allergic rhinitis , skin disorders
10.
Soho (Indonesia)
Roxithromycin
bacterial infections
11.
Baxter (Austria, Germany)
Trofosfamide
malignant neoplasms
12. (†)
Schering (Italy)
Trofosfamide
malignant neoplasms
14. (†)
Cantabria (Spain)
Co-trimoxazole
bacterial infections
15.
Pierre fabre medicament (Romania)
milnacipran